mesalamine has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koo, TH | 1 |
| Choi, WJ | 1 |
| Han, SH | 1 |
| Kim, SY | 1 |
| Lee, JH | 1 |
1 other study available for mesalamine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
[A Case of Small Bowel Diffuse Large B-cell Lymphoma Mimicking Crohn's Disease].
Topics: Aged; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Capsule Endoscopy; Crohn Disease; | 2015 |